Adynxx Reports Second Quarter 2019 Financial Results
August 14, 2019 07:00 ET
|
Adynxx, Inc.
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical
May 10, 2019 06:00 ET
|
Adynxx, Inc.
Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously...